Specifically, the VLA-4—VCAM1 interaction triggers the NF-κB signaling pathway in MM-MSCs and the transcription and secretion of IL-6, a major MM cell growth factor [5]. The gene discussed is VCAM1; the disease is Miyoshi myopathy.